Internal correspondence reveals Coinbase co-founder Fred Ehrsam was personally briefed on and facilitated a multi-million dollar investment from the convicted sex offender, arranged by Tether's Brock Pierce.
Newly filed state documents reveal the geographic breakdown of Amazon's latest workforce reduction in Washington, with T-Mobile and International Paper also submitting layoff notices affecting hundreds more employees across the state.
The U.S. Treasury Department has outlined its borrowing needs for the first half of 2026, projecting $574 billion in net marketable debt for Q1 followed by a significantly lower $109 billion for Q2, amid adjustments to cash flow forecasts and federal cash balances.
As economic anxieties mount, strategic diversification remains paramount. We examine two Vanguard ETFs that could offer stability and long-term growth opportunities should market conditions deteriorate.
New data reveals a two-horse race in mining sector legal advisory, with Webber Wentzel leading by total deal value and Blake Cassels & Graydon topping the charts by number of transactions in a year marked by megadeals.
At a Singapore aviation conference, FAA Administrator Bryan Bedford publicly accepted the NTSB's findings that agency failures contributed to a mid-air collision that claimed 67 lives, vowing to implement safety reforms.
Israel and Egypt have initiated a tightly controlled pilot reopening of the Rafah border crossing, a move tied to the broader U.S.-backed peace framework. The initial phase permits a small number of pre-vetted individuals to cross daily under heavy security coordination.
A San Antonio family's morning commute turned to terror when a driver, angered by a brief honk, opened fire on their vehicle, critically wounding a child in the backseat.
While both ETFs target the high-flying U.S. technology sector, a closer look reveals critical distinctions in diversification, concentration risk, and liquidity that could sway long-term portfolio outcomes.
New long-term results from the pivotal EMBARK trial indicate ELEVIDYS, Sarepta's gene therapy, continues to alter the disease trajectory for boys with Duchenne muscular dystrophy, with no new safety concerns emerging over three years.
Venture capital titans Marc Andreessen and Ben Horowitz lead a massive $50.8 million fundraising effort for a new super PAC, 'Leading the Future,' aiming to shape AI-friendly policies in the 2026 elections.
Bitcoin struggles to find a floor, trading near November lows as the nomination of Kevin Warsh for Fed Chair fails to spark a rally. Persistent outflows from US spot ETFs and a broader risk-off mood compound the pressure, raising fresh doubts about the cryptocurrency's 'digital gold' narrative.
Clinical-stage biopharma Mineralys Therapeutics has filed its New Drug Application for lorundrostat, a potential treatment for resistant hypertension, following positive results from multiple trials. The move positions the company for a potential 2026 market entry and has drawn upgraded price targets from analysts.
